Semin intervent Radiol 2011; 28(2): 252-257
DOI: 10.1055/s-0031-1280675
© Thieme Medical Publishers

Hepatic Arterial Embolization Complicated by Acute Cholecystitis

Rajesh P. Shah1 , Karen T. Brown1
  • 1Section of Interventional Radiology, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York
Further Information

Publication History

Publication Date:
16 June 2011 (online)

ABSTRACT

Hepatic arterial embolization (HAE) is a treatment used in the management of primary and some metastatic hepatic tumors. Complications of HAE are similar to those seen in other treatments, particularly transcatheter arterial chemoembolization (TACE), but without the possibility for chemotherapy related side effects. Particle reflux into the cystic artery is generally clinically occult but gallbladder ischemia severe enough to require cholecystostomy tube placement can occur. The authors discuss the case of a patient who underwent HAE and subsequently required a cholecystostomy tube due to development of acute cholecystitis.

REFERENCES

  • 1 Llovet J M, Real M I, Montaña X Barcelona Liver Cancer Group et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.  Lancet. 2002;  359 (9319) 1734-1739
  • 2 Lo C M, Ngan H, Tso W K et al.. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.  Hepatology. 2002;  35 (5) 1164-1171
  • 3 Chang J M, Tzeng W S, Pan H B, Yang C F, Lai K H. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study.  Cancer. 1994;  74 (9) 2449-2453
  • 4 Marelli L, Stigliano R, Triantos C et al.. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.  Cardiovasc Intervent Radiol. 2007;  30 (1) 6-25
  • 5 Martin RCG, Robbins K, Tomalty D et al.. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.  World J Surg Oncol. 2009;  7 80
  • 6 Brown K T, Koh B Y, Brody L A et al.. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms.  J Vasc Interv Radiol. 1999;  10 (4) 397-403
  • 7 Sakamoto I, Aso N, Nagaoki K et al.. Complications associated with transcatheter arterial embolization for hepatic tumors.  Radiographics. 1998;  18 (3) 605-619
  • 8 López-Benítez R, Richter G M, Kauczor H U et al.. Analysis of nontarget embolization mechanisms during embolization and chemoembolization procedures.  Cardiovasc Intervent Radiol. 2009;  32 (4) 615-622
  • 9 Michels N A. Newer anatomy of the liver and its variant blood supply and collateral circulation.  Am J Surg. 1966;  112 (3) 337-347
  • 10 Bismuth H, Morino M, Sherlock D et al.. Primary treatment of hepatocellular carcinoma by arterial chemoembolization.  Am J Surg. 1992;  163 (4) 387-394
  • 11 Wagnetz U, Jaskolka J, Yang P, Jhaveri K S. Acute ischemic cholecystitis after transarterial chemoembolization of hepatocellular carcinoma: incidence and clinical outcome.  J Comput Assist Tomogr. 2010;  34 (3) 348-353
  • 12 Atassi B, Bangash A K, Lewandowski R J et al.. Biliary sequelae following radioembolization with Yttrium-90 microspheres.  J Vasc Interv Radiol. 2008;  19 (5) 691-697
  • 13 Pietrafitta J J, Anderson B G, O'Brien M J, Deckers P J. Cholecystitis secondary to infusion chemotherapy.  J Surg Oncol. 1986;  31 (4) 287-293
  • 14 Sakamoto I, Aso N, Nagaoki K et al.. Complications associated with transcatheter arterial embolization for hepatic tumors.  Radiographics. 1998;  18 (3) 605-619
  • 15 Poggi G, Pozzi E, Riccardi A et al.. Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver.  Anticancer Res. 2010;  30 (12) 5159-5164
  • 16 Wang X, Shah R P, Maybody M et al.. Cystic artery localization using a three-dimensional angiography vessel tracking system compared with conventional two-dimensional angiography.  J Vasc Interv Radiol. 2011;  22 549-550
  • 17 Miyayama S, Matsui O, Nishida H et al.. Transcatheter arterial chemoembolization for unrespectable hepatocellular carcinoma fed by the cystic artery.  J Vasc Interv Radiol. 2003;  14 1156-1161
  • 18 Miyayama S, Matsui O, Taki K et al.. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization.  Cardiovasc Intervent Radiol. 2006;  29 (1) 39-48

Rajesh P ShahM.D. 

Section of Interventional Radiology, Department of Radiology, Memorial Sloan-Kettering Cancer Center

1275 York Avenue, H-118A, New York, NY 10065

Email: shahr@mskcc.org

    >